Pnc Financial Services Group, Inc. Vir Biotechnology, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $156 Billion
- Q3 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 6,289 shares of VIR stock, worth $64,650. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,289
Previous 9,719
35.29%
Holding current value
$64,650
Previous $86,000
45.35%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding VIR
# of Institutions
214Shares Held
87MCall Options Held
127KPut Options Held
1.19M-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$172 Million1.03% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$169 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$135 Million0.0% of portfolio
-
State Street Corp Boston, MA5.63MShares$57.8 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.57MShares$36.7 Million0.63% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $1.36B
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...